Chemoinformaics analysis of chrysanthenyl acetate ii
| Molecular Weight | 194.274 | nRot | 1 |
| Heavy Atom Molecular Weight | 176.13 | nRig | 9 |
| Exact Molecular Weight | 194.131 | nRing | 3 |
| Solubility: LogS | -3.65 | nHRing | 0 |
| Solubility: LogP | 3.298 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 33.6463 |
| nHD | 0 | BPOL | 20.6617 |
| QED | 0.473 |
| Synth | 4.494 |
| Natural Product Likeliness | 2.804 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.003 |
| HIA | 0.02 |
| CACO-2 | -4.406 |
| MDCK | 0.0000268 |
| BBB | 0.956 |
| PPB | 0.716577 |
| VDSS | 1.437 |
| FU | 0.360114 |
| CYP1A2-inh | 0.286 |
| CYP1A2-sub | 0.107 |
| CYP2c19-inh | 0.098 |
| CYP2c19-sub | 0.798 |
| CYP2c9-inh | 0.156 |
| CYP2c9-sub | 0.312 |
| CYP2d6-inh | 0.028 |
| CYP2d6-sub | 0.468 |
| CYP3a4-inh | 0.09 |
| CYP3a4-sub | 0.285 |
| CL | 9.65 |
| T12 | 0.122 |
| hERG | 0.011 |
| Ames | 0.006 |
| ROA | 0.36 |
| SkinSen | 0.097 |
| Carcinogencity | 0.075 |
| EI | 0.084 |
| Respiratory | 0.932 |
| NR-Aromatase | 0.003 |
| Antiviral | No |
| Prediction | 0.603412 |